10.50 - 11.12
3.81 - 12.83
1.80M / 1.60M (Avg.)
158.14 | 0.07
Analyze analyst forecasts for the company and compare them with competitors.
897.00M
The estimated revenue has increased from the previous period.
247.65M
The estimated EBITDA has increased from the previous period.
1.09
The estimated EPS has increased from the previous period.
363.49M
The estimated net income has increased from the previous period.
190.09M
The estimated EBIT has increased from the previous period.
630.50M
The estimated SG&A expenses have increased from the previous period.
Analyze DCF forecasts for the company and compare them with competitors.
2.96M
Revenue has increased from the previous period.
No Data
No DCF data available for this metric in the selected year.
-17.71M
EBITDA has increased from the previous period.
-599.18%
EBITDA margin has decreased from the previous period.
-17.82M
EBIT has increased from the previous period.
-602.91%
EBIT margin has decreased from the previous period.
110.35K
Depreciation has increased from the previous period.
14.70M
Total cash has decreased from the previous period.
497.48%
Cash percentage has increased from the previous period.
12.24M
Receivables have increased from the previous period.
414.21%
Receivables percentage has increased from the previous period.
6.92M
Inventories have increased from the previous period.
234.17%
Inventory percentage has increased from the previous period.
4.28M
Accounts payable has increased from the previous period.
144.67%
Payables percentage has increased from the previous period.
-68.97M
Capital expenditure has increased from the previous period.
-2333.68%
CapEx percentage has increased from the previous period.
9.21%
WACC is unchanged from the previous period.
9.08%
Cost of equity is unchanged from the previous period.
293.12%
Cost of debt is unchanged from the previous period.
1.06
Beta is unchanged from the previous period.
333.90M
Diluted shares outstanding is unchanged from the previous period.
1.56M
Total debt is unchanged from the previous period.
3.49B
Total equity is unchanged from the previous period.
3.49B
Total capital is unchanged from the previous period.
0.04%
Debt weighting is unchanged from the previous period.
99.96%
Equity weighting is unchanged from the previous period.
-17.82M
EBIAT has increased from the previous period.
-103.26M
UFCF has decreased from the previous period.
2.00%
Long-term growth rate is unchanged from the previous period.
205.99M
Terminal value is unchanged from the previous period.
73.26M
Enterprise value is unchanged from the previous period.
-113.70M
Net debt is unchanged from the previous period.
186.97M
Equity value is unchanged from the previous period.
0.56
Equity value per share is unchanged from the previous period.
View analysts' price targets and recommendations, and compare them with competitors.
$4.18
Analysts expect the stock price to decrease by 62.24%.
Buy
Positive consensus among analysts.
